Research Grade Votumumab (DHK11401)

Catalog No.

DHK11401

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG3-kappa

Clonality

Monoclonal

Target

Tumor Antigen CTAA16.88

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

Technetium (99mTc) votumumab, CAS: 148189-70-2

Clone ID

Votumumab

Anti-CD20 treatment for B-cell malignancies: current status and future directions, PMID: 32933335

The European Medicines Agency review of ofatumumab (Arzerra®) for the treatment of chronic lymphocytic leukemia in patients refractory to fludarabine and alemtuzumab: summary of the scientific assessment of the European medicines agency committee for medicinal products for human use, PMID: 21156732

Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapy, PMID: 20712081

Document Download

Research Grade Votumumab.pdf